153 related articles for article (PubMed ID: 31738620)
1. Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents.
Cevik M; Orkin C
Expert Opin Investig Drugs; 2019 Dec; 28(12):1021-1024. PubMed ID: 31738620
[No Abstract] [Full Text] [Related]
2. Capsid proteins of enveloped viruses as antiviral drug targets.
Klumpp K; Crépin T
Curr Opin Virol; 2014 Apr; 5():63-71. PubMed ID: 24607800
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
Thenin-Houssier S; Valente ST
Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach.
Romashov LV; Ananikov VP
Org Biomol Chem; 2016 Dec; 14(45):10593-10598. PubMed ID: 27714265
[TBL] [Abstract][Full Text] [Related]
5. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model.
Yant SR; Mulato A; Hansen D; Tse WC; Niedziela-Majka A; Zhang JR; Stepan GJ; Jin D; Wong MH; Perreira JM; Singer E; Papalia GA; Hu EY; Zheng J; Lu B; Schroeder SD; Chou K; Ahmadyar S; Liclican A; Yu H; Novikov N; Paoli E; Gonik D; Ram RR; Hung M; McDougall WM; Brass AL; Sundquist WI; Cihlar T; Link JO
Nat Med; 2019 Sep; 25(9):1377-1384. PubMed ID: 31501601
[TBL] [Abstract][Full Text] [Related]
6. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
[TBL] [Abstract][Full Text] [Related]
7. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
Domenech R; Neira JL
Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly.
Fader LD; Bethell R; Bonneau P; Bös M; Bousquet Y; Cordingley MG; Coulombe R; Deroy P; Faucher AM; Gagnon A; Goudreau N; Grand-Maître C; Guse I; Hucke O; Kawai SH; Lacoste JE; Landry S; Lemke CT; Malenfant E; Mason S; Morin S; O'Meara J; Simoneau B; Titolo S; Yoakim C
Bioorg Med Chem Lett; 2011 Jan; 21(1):398-404. PubMed ID: 21087861
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A.
Chen K; Tan Z; He M; Li J; Tang S; Hewlett I; Yu F; Jin Y; Yang M
Chem Biol Drug Des; 2010 Jul; 76(1):25-33. PubMed ID: 20456372
[TBL] [Abstract][Full Text] [Related]
10. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981
[TBL] [Abstract][Full Text] [Related]
11. Novel Antiretroviral Agents.
Cambou MC; Landovitz RJ
Curr HIV/AIDS Rep; 2020 Apr; 17(2):118-124. PubMed ID: 32052271
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment.
Xu S; Sun L; Huang B; Liu X; Zhan P
Future Med Chem; 2020 Jul; 12(14):1281-1284. PubMed ID: 32483985
[No Abstract] [Full Text] [Related]
13. The importance of targeting HIV reservoirs: preclinical insights on current and potential therapeutic opportunities.
Cory TJ
Expert Opin Ther Targets; 2019 Dec; 23(12):987-989. PubMed ID: 31815559
[No Abstract] [Full Text] [Related]
14. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155
[TBL] [Abstract][Full Text] [Related]
15. The capsid revolution.
Taylor IA; Fassati A
J Mol Cell Biol; 2024 Apr; 15(11):. PubMed ID: 38037430
[TBL] [Abstract][Full Text] [Related]
16. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
[TBL] [Abstract][Full Text] [Related]
17. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719
[TBL] [Abstract][Full Text] [Related]
18. Promising Early Results for Potent, Long-Acting HIV Injection.
Abbasi J
JAMA; 2020 Aug; 324(6):539. PubMed ID: 32780126
[No Abstract] [Full Text] [Related]
19. FAITH - Fast Assembly Inhibitor Test for HIV.
Hadravová R; Rumlová M; Ruml T
Virology; 2015 Dec; 486():78-87. PubMed ID: 26410239
[TBL] [Abstract][Full Text] [Related]
20. Clinical targeting of HIV capsid protein with a long-acting small molecule.
Link JO; Rhee MS; Tse WC; Zheng J; Somoza JR; Rowe W; Begley R; Chiu A; Mulato A; Hansen D; Singer E; Tsai LK; Bam RA; Chou CH; Canales E; Brizgys G; Zhang JR; Li J; Graupe M; Morganelli P; Liu Q; Wu Q; Halcomb RL; Saito RD; Schroeder SD; Lazerwith SE; Bondy S; Jin D; Hung M; Novikov N; Liu X; Villaseñor AG; Cannizzaro CE; Hu EY; Anderson RL; Appleby TC; Lu B; Mwangi J; Liclican A; Niedziela-Majka A; Papalia GA; Wong MH; Leavitt SA; Xu Y; Koditek D; Stepan GJ; Yu H; Pagratis N; Clancy S; Ahmadyar S; Cai TZ; Sellers S; Wolckenhauer SA; Ling J; Callebaut C; Margot N; Ram RR; Liu YP; Hyland R; Sinclair GI; Ruane PJ; Crofoot GE; McDonald CK; Brainard DM; Lad L; Swaminathan S; Sundquist WI; Sakowicz R; Chester AE; Lee WE; Daar ES; Yant SR; Cihlar T
Nature; 2020 Aug; 584(7822):614-618. PubMed ID: 32612233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
